Moderna says that the Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., cut funding for an mRNA ...

The administration cited concerns about mRNA technology; however, Moderna says the vaccine causes a "rapid, potent and ...

The Department of Health and Human Services is ending a $766 million contract with the vaccine company Modern to develop an ...

Moderna announced positive interim results from an early-stage trial of a vaccine that targeted bird flu virus.

The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

Cidara Therapeutics' CD388 is aimed at providing universal protection with a single yearly dose for each flu season. See why ...

That would be a mistake, health experts say. A severe flu season ahead? Amid warning signs of a potentially severe flu season ahead, those experts worry "vaccine fatigue" will keep people from getting ...

La Sasso and Ole Miss have arguably faced more adversity than any other team, but so far at the NCAA Championship it has been ...

Lily McGarry’s mother opens up about ‘terrifying’ moment hospital called to say her daughter was in a coma as family ...

Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world ...